StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a ...

Cantor Fitzgerald upgraded shares of Tourmaline Bio (NASDAQ:TRML – Free Report) to a strong-buy rating in a report published ...

Fintel reports that on October 18, 2024, Cantor Fitzgerald downgraded their outlook for Lilium N.V. (NasdaqGS:LILM) from ...

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Closing Bell' to discuss the bullish case for ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 60.77% ...

On Thursday, Snap Inc (SNAP) stock saw a decline, ending the day at $10.46 which represents a decrease of $-0.30 or -2.79% from the prior close of $10.76. The stock opened at $10.6 and touched a low ...

CME Group Inc. is amping up the battle for market share in US Treasury futures, pulling all stops to thwart Howard Lutnick’s ...

Vertex's diverse pipeline positions it for a growth, despite challenges in launching new drugs like Casgevy and suzetrigine.

Former President Donald Trump is trading the rally stage for comedy Thursday night as he headlines the annual Al Smith ...

Closely-watched cases could have implications for areas of corporate law that have come up repeatedly in attorneys' ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...